# Sitagliptin in Combination With Metformin and Sulfonylurea

> **NCT00686634** · PHASE4 · COMPLETED · sponsor: **Charles Drew University of Medicine and Science** · enrollment: 108 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Sitagliptin

## Key facts

- **NCT ID:** NCT00686634
- **Lead sponsor:** Charles Drew University of Medicine and Science
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 108 (ACTUAL)
- **Last updated:** 2014-11-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00686634

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00686634, "Sitagliptin in Combination With Metformin and Sulfonylurea". Retrieved via MORVS 2026-09-29 from https://api.morvs.ai/clinical/NCT00686634. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*